Skip to main content

Part of the book series: Bayer AG Centenary Symposium ((BAYER))

  • 226 Accesses

Abstract

The brain is the pacemaker of the human body. If this pacemaker does not function life is not possible. In the brain there are more than 10 billion neurons. Each neuron makes more than a thousand contacts. The axons of the neuron branches ramify into several end terminals which are in contact with other cell bodies and dendrites. The propagation of the impulse is electric in the axons and the dendrites; in the synaptic cleft, however, the impulse is propagated via a neurotransmitter. This highly effective chemical substance is released from the terminal and stimulates a postsynaptic receptor. The neurons, the axons, and the dendrites are embedded in lipid membranes and are therefore difficult to influence by chemical drugs. However, in the synaptic cleft the propagation of the nerve impulse is more open for manipulation. This is a part of the brain where chemical drugs can easily influence the brain function. Most of the psychotropic drugs used at present have effects at the synaptic level on the metabolism, on the release and the reuptake of neurotransmitters, and on the receptors.

This work was supported by grants from the Swedish Medical Research Council, the Lundbeck Foundation, the Fredrik and Ingrid Thuring Foundation, the Old Servant’s Foundation, the Greta and Johan Kock Foundation, the Hjalmar Svensson Foundation, and the Söderström-Königska Hospital Foundation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Balldin J, Gottfries CG, Karlsson I, Lindstedt G, Längström G, Wilinder J (1983) Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry 143: 277–281

    Article  PubMed  CAS  Google Scholar 

  2. Balldin J, Gottfries CG, Karlsson I, Lindstedt G, Lingström G, Svennerholm L (1988) Relationship between DST and the serotonergic system. Results from treatments with two 5-HT reuptake blockers in dementia disorders. Int J Geriatr Psychiatry 3: 17–26

    Article  Google Scholar 

  3. Brine G, Gottfries CG, Karlsson I, Lekman A, Parnetti L, Svennerholm L (1989) Monoamine metabolites in CSF correlated to psychological variables in patients with dementia of Alzheimer type. Alzh Dem Ass Disord (to be published )

    Google Scholar 

  4. Carlsson A (1986) Neurotransmitters in old age and dementia. In: Heffner H, Moschel G, Sartorius N (eds) Mental health in the elderly: a review of the present state of research. Springer, Berlin Heidelberg New York, pp 154–161

    Google Scholar 

  5. Carlsson A, Winblad B (1976) Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38: 271–276

    Article  PubMed  CAS  Google Scholar 

  6. Drachmann DA, Leavitt J (1974) Human memory and the cholinergic system. Arch Neurol 30: 113–121

    Google Scholar 

  7. Gottfries CG (1985) Review. Alzheimer’s disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245–252

    Article  PubMed  CAS  Google Scholar 

  8. Gottfries CG (1986) Nosological aspects of differential typology of dementia of Alzheimer type. In: Bergener M (ed) Dimensions in aging. Academic, London, pp 207–219

    Google Scholar 

  9. Gottfries CG, Brine G, Gullberg B, Steen G (1982) A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1: 311–330

    Article  PubMed  CAS  Google Scholar 

  10. Gottfries CG, Adolfsson R, Aquilonius SM, Carlsson A, Eckernäs SE, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type ( AD/SDAT ). Neurobiol Aging 4: 261–271

    Article  PubMed  CAS  Google Scholar 

  11. Gottfries CG, Bartfai T, Carlsson A, Eckernäs SA, Svennerholm L (1986) Multiple biochemical deficits in both gray and white matter of Alzheimer brains. Prog Neuropsychopharmacol Biol Psychiatry 10: 405–413

    Article  PubMed  CAS  Google Scholar 

  12. Green AR (1985) Neuropharmacology of serotonin. Oxford University Press, Oxford

    Google Scholar 

  13. Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985) Review. Transmitter deficits in Alzheimer’s disease. Neurochem Int 7: 545–563

    Article  PubMed  CAS  Google Scholar 

  14. Jorm AF, Korten E, Henderson S (1987) Review article. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465–479

    Article  PubMed  CAS  Google Scholar 

  15. Marcusson JO, Alafuzoff I, Bäckström IT, Ericson E, Gottfries CG, Winblad B (1987) Hydroxytryptamine-sensitive (3H) imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders. Brain Res 425: 137–145

    Article  PubMed  CAS  Google Scholar 

  16. McEwen BS, Brinton RE (1987) Neuroendocrine aspects of adaptation. Prog Brain Res 72: 11–26

    Article  PubMed  CAS  Google Scholar 

  17. McGeer EG, Fibiger HC, McGeer PL, Wickson V (1971) Aging and brain enzymes. Exp Gerontol 6: 391–396

    Article  PubMed  CAS  Google Scholar 

  18. Nemeroff CB (1980) Neurotensin: perchance and endogenous neuroleptic? Biol Psychiatry 15: 283–302

    PubMed  CAS  Google Scholar 

  19. Nemeroff CB, Lurringer D, Prange AJ (1983) Neurotensin and bombesin. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 16. Plenum, New York

    Google Scholar 

  20. Nordberg A, Nilsson L, Adern A, Winblad B (1988) Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. (Abstracts first international conference on Alzheimer disease and related disorders, Las Vegas, 6–9 Sept 1988). Alzh Dis Ass Disord 2: 212

    Article  Google Scholar 

  21. Nyberg P, Nordberg A, Wester P, Winblad B (1983) Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson’s disease. Neurochem Pathol 1: 193–202

    Article  CAS  Google Scholar 

  22. Nyth AL, Gottfries CG, Elgen K, Engedal K, Harenko A, Karlsson I, Koskinen T, Larsson L, Nygaard H, Samuelsson SM, Yli-Kerttula A (1988) The effect of citalopram in dementia disorders. A Scandinavian multi-center study. Poster at the CINP congress in Munich, Aug 15–19, 1988

    Google Scholar 

  23. Parnetti L, Gottfries J, Karlsson I, Lângström G, Gottfries CG, Svennerholm L (1987) Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high-performance liquid chromatography and gas-chromatography mass spectometry. Acta Psychiatr Scand 75: 542–548

    Article  PubMed  CAS  Google Scholar 

  24. Perry EK, Perry RH (1980) The cholinergic system in Alzheimer’s disease. In: Roberts RI (ed) Biochemistry of dementia. Wiley, Chichester, pp 135–183

    Google Scholar 

  25. Svanborg A, Landahl S, Mellström D (1983) Basic issues of health care. In: Thomas H, Maddox GL (eds) New perspectives on old age. A message to decision makers. Springer, Berlin Heidelberg New York, pp 31–52

    Google Scholar 

  26. Terenius L, Wahlström A, Lindström L, Widerlöv E (1976) Increased CSF levels of endorphines in chronic psychoses. Neurosci Lett 3: 157–162

    Article  PubMed  CAS  Google Scholar 

  27. Wallin A, Carlsson A, Ekman R, Gottfries CG, Karlsson I, Svennerholm L, Widerlöv E (1989) Hypothalamic biochemical disturbances in aging and in dementing disorders. To be published

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gottfries, C.G. (1989). Neurotransmitters in the Brain. In: Wolff, HP., Fleckenstein, A., Philipp, E.O. (eds) Drug Research and Drug Development in the 21st Century. Bayer AG Centenary Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74615-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74615-4_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50961-5

  • Online ISBN: 978-3-642-74615-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics